D i a b e t e s

Case Study

* * *

A New Perspective on Type 1 and Type 2

By Paul J.Tubiana

http://www.diabetescasestudy.com

Website Copyright 2003-2006 Paul J. Tubiana All rights reserved.

This document may not be reproduced or translated in whole or in part by any means, and may not be sold, distributed, downloaded, otherwise transferred, or used to endorse a product or service without express written permission.

Disclaimer: The statements presented in this document are intended for informative purposes only. These statements have not been evaluated by any third party, public or private. The statements contained herein are solely the opinions of the author, and are not intended to diagnose, treat, or cure any condition, symptom, or ailment, nor to suggest nor prescribe any course of action. The author expressly does not accept or assume any responsibility or liability for its use, misuse, or interpretation and/or any consequences or damages. It is the reader's responsibility to seek his or her own professional medical advice and to do the research that may confirm or deny the validity of this presentation. The author expressly does not endorse any product, service, or method. The following brand names wherever they may appear in this document are registered trademarks of their respective companies and/or affiliates and/or partnerships and/or holding companies and/or licensors and/or assignees, to the author’s best knowledge as follow: Humulin® R insulin, Humulin® N insulin, and Humalog® insulin are registered trademarks of Eli Lilly and Company, Indianapolis, IN USA; Lantus® insulin is a registered trademark of Aventis Pharma Deutschland GmbH, and/ or Hoechst AG, Frankfurt am Main, Germany, and/or its related affiliates; NovoLog® is a registered trademark of NovoNordisk A/S, Bagsvaerd, Denmark; Glucophage® XR is a registered trademark of Lyonnaise Industrielle Pharmaceutique, s.a. (LIPHA, s.a.), Lyon, France and is licensed to Bristol-Myers Squibb Company, Princeton, NJ USA; Zithromax® is a registered trademark of Pfizer, Inc. USA; Augmentin® 1000 XR is a registered trademark of SmithKline Beecham Corp., Philadelphia, PA USA ; Synthroid® is a registered trademark of Abbott Laboratories Corp., Abbott Park, IL USA and/or Knoll Pharmaceutical Corp., Mount Olive, NJ USA and/or Travenol Laboratories, Inc., Morton Grove, IL USA; Quest Diagnostics® is a registered trademark of Quest Diagnostics Incorporated.